TY - JOUR
T1 - Incidence and risk of major heart diseases in middle-aged adults with moderate to severe vision impairment
T2 - A population-based cohort study
AU - Hsueh, Chun Mei
AU - Wey, Jing Hwa
AU - Yeh, Jong Shiuan
AU - Wu, Chien Hua
AU - Liou, Tsan Hon
AU - Chang, Kwang Hwa
N1 - Funding Information:
Funding This study was supported by the Social and Family Affairs Administration, Ministry of Health and Welfare (grant no 104037), Taipei, and Wan Fang Hospital (grant no 103-wf-eva-28), Taipei Medical University, Taipei, Taiwan.
Publisher Copyright:
© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.
PY - 2019/8/1
Y1 - 2019/8/1
N2 - Background/aim: To estimate the incidence and risk of major adverse cardiovascular events (MACEs), including heart failure and ischaemic heart disease, among middle-aged people with a visual disability (VD). Methods: We used a national health insurance research database to conduct a population-based cohort study from 1 January 2000 to 31 December 2013. Patients with VD aged 35∼65 years were recruited. For each VD patient, five age-matched, sex-matched and comorbidity-matched patients were randomly selected and recruited as controls. Control patients had no documented disability. Results: This study recruited 978 patients with VD (mean age±SD, 55.1±7.8 years; 48.9% male) and 4677 controls. Compared with the same sex of the controls, women with VD had higher incidence of MACE 1 (7.9 vs 2.8/1000 person-years, p<0.001), MACE 2 (27.5 vs 16.9/1000 person-years, p<0.001), MACE 3 (3.7 vs 1.4/1000 person-years, p<0.005) and MACE 4 (4.5 vs 2.5/1000 person-years, p<0.05), and men with VD had higher incidence of MACE 1 (4.6 vs 2.0/1000 person-years, p<0.005). Compared with the controls, patients with VD had lower cumulative MACE 1∼MACE 4-free probabilities and had an independently higher risk of MACE 1∼MACE 4 during the 13-year study, yielding an adjusted hazard ratio range of 1.31∼2.75. Those persons with VD who had diabetes and hypertension had greater risks of MACE 1∼MACE 4. Conclusions: Middle-aged adults with VD were at risk of MACEs. A programme for MACE prevention is important for middle-aged people with VD. This is especially true for women and for those who also have diabetes and hypertension.
AB - Background/aim: To estimate the incidence and risk of major adverse cardiovascular events (MACEs), including heart failure and ischaemic heart disease, among middle-aged people with a visual disability (VD). Methods: We used a national health insurance research database to conduct a population-based cohort study from 1 January 2000 to 31 December 2013. Patients with VD aged 35∼65 years were recruited. For each VD patient, five age-matched, sex-matched and comorbidity-matched patients were randomly selected and recruited as controls. Control patients had no documented disability. Results: This study recruited 978 patients with VD (mean age±SD, 55.1±7.8 years; 48.9% male) and 4677 controls. Compared with the same sex of the controls, women with VD had higher incidence of MACE 1 (7.9 vs 2.8/1000 person-years, p<0.001), MACE 2 (27.5 vs 16.9/1000 person-years, p<0.001), MACE 3 (3.7 vs 1.4/1000 person-years, p<0.005) and MACE 4 (4.5 vs 2.5/1000 person-years, p<0.05), and men with VD had higher incidence of MACE 1 (4.6 vs 2.0/1000 person-years, p<0.005). Compared with the controls, patients with VD had lower cumulative MACE 1∼MACE 4-free probabilities and had an independently higher risk of MACE 1∼MACE 4 during the 13-year study, yielding an adjusted hazard ratio range of 1.31∼2.75. Those persons with VD who had diabetes and hypertension had greater risks of MACE 1∼MACE 4. Conclusions: Middle-aged adults with VD were at risk of MACEs. A programme for MACE prevention is important for middle-aged people with VD. This is especially true for women and for those who also have diabetes and hypertension.
KW - heart failure
KW - incidence
KW - ischemic heart disease
KW - vision disability
UR - http://www.scopus.com/inward/record.url?scp=85053134448&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85053134448&partnerID=8YFLogxK
U2 - 10.1136/bjophthalmol-2018-312471
DO - 10.1136/bjophthalmol-2018-312471
M3 - Article
AN - SCOPUS:85053134448
SN - 0007-1161
VL - 103
SP - 1054
EP - 1059
JO - British Journal of Ophthalmology
JF - British Journal of Ophthalmology
IS - 8
ER -